| Application number | Title of the application | Filing Date | Status |
|---|
| 08/384524 | EFFECTOR PROTEINS OF RAPAMYCIN | Feb 12, 1995 | Abandoned |
Array
(
[id] => 3722236
[patent_doc_number] => 05784992
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-28
[patent_title] => 'Apparatus for injecting avian embryo muscle tissue in ovo'
[patent_app_type] => 1
[patent_app_number] => 8/383703
[patent_app_country] => US
[patent_app_date] => 1995-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7388
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/784/05784992.pdf
[firstpage_image] =>[orig_patent_app_number] => 383703
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/383703 | Apparatus for injecting avian embryo muscle tissue in ovo | Jan 31, 1995 | Issued |
Array
(
[id] => 3686542
[patent_doc_number] => 05643787
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Adenocarcinoma cell basement membrane composition'
[patent_app_type] => 1
[patent_app_number] => 8/381384
[patent_app_country] => US
[patent_app_date] => 1995-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13035
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643787.pdf
[firstpage_image] =>[orig_patent_app_number] => 381384
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/381384 | Adenocarcinoma cell basement membrane composition | Jan 30, 1995 | Issued |
Array
(
[id] => 3993298
[patent_doc_number] => 05858355
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'IRAP gene as treatment for arthritis'
[patent_app_type] => 1
[patent_app_number] => 8/381603
[patent_app_country] => US
[patent_app_date] => 1995-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 26
[patent_no_of_words] => 22082
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858355.pdf
[firstpage_image] =>[orig_patent_app_number] => 381603
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/381603 | IRAP gene as treatment for arthritis | Jan 26, 1995 | Issued |
Array
(
[id] => 3774506
[patent_doc_number] => 05849991
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Mice homozygous for an inactivated .alpha. 1,3-galactosyl transferase gene'
[patent_app_type] => 1
[patent_app_number] => 8/378617
[patent_app_country] => US
[patent_app_date] => 1995-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 47
[patent_no_of_words] => 34016
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849991.pdf
[firstpage_image] =>[orig_patent_app_number] => 378617
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/378617 | Mice homozygous for an inactivated .alpha. 1,3-galactosyl transferase gene | Jan 25, 1995 | Issued |
Array
(
[id] => 3608800
[patent_doc_number] => 05589466
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => 'Induction of a protective immune response in a mammal by injecting a DNA sequence'
[patent_app_type] => 1
[patent_app_number] => 8/380131
[patent_app_country] => US
[patent_app_date] => 1995-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 23624
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589466.pdf
[firstpage_image] =>[orig_patent_app_number] => 380131
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/380131 | Induction of a protective immune response in a mammal by injecting a DNA sequence | Jan 25, 1995 | Issued |
Array
(
[id] => 3695619
[patent_doc_number] => 05661133
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Expression of a protein in myocardium by injection of a gene'
[patent_app_type] => 1
[patent_app_number] => 8/376521
[patent_app_country] => US
[patent_app_date] => 1995-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 22
[patent_no_of_words] => 5981
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661133.pdf
[firstpage_image] =>[orig_patent_app_number] => 376521
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/376521 | Expression of a protein in myocardium by injection of a gene | Jan 22, 1995 | Issued |
Array
(
[id] => 4192416
[patent_doc_number] => 06130206
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-10
[patent_title] => 'Treating viral infections associated with chronic fatigue with dsRNA'
[patent_app_type] => 1
[patent_app_number] => 8/376457
[patent_app_country] => US
[patent_app_date] => 1995-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2182
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/130/06130206.pdf
[firstpage_image] =>[orig_patent_app_number] => 376457
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/376457 | Treating viral infections associated with chronic fatigue with dsRNA | Jan 22, 1995 | Issued |
Array
(
[id] => 3786666
[patent_doc_number] => 05780009
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => 'Direct gene transfer into the ruminant mammary gland'
[patent_app_type] => 1
[patent_app_number] => 8/377016
[patent_app_country] => US
[patent_app_date] => 1995-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 11419
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/780/05780009.pdf
[firstpage_image] =>[orig_patent_app_number] => 377016
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/377016 | Direct gene transfer into the ruminant mammary gland | Jan 19, 1995 | Issued |
| 08/371530 | DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY | Jan 16, 1995 | Abandoned |
Array
(
[id] => 4055365
[patent_doc_number] => 05932780
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Transgenic non-human animal assay system for anti-cholinesterase substances'
[patent_app_type] => 1
[patent_app_number] => 8/370156
[patent_app_country] => US
[patent_app_date] => 1995-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 28
[patent_no_of_words] => 37833
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932780.pdf
[firstpage_image] =>[orig_patent_app_number] => 370156
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/370156 | Transgenic non-human animal assay system for anti-cholinesterase substances | Jan 8, 1995 | Issued |
| 08/368602 | TREATMENT OF TUMORS BY TRANSDUCING TUMOR CELLS WITH NEGATIVE SELECTIVE MARKERS, CONTACTING THE TUMOR CELLS WITH AN INTERACTION AGENT, AND EXPOSING THE CELLS TO RADIATION | Jan 3, 1995 | Abandoned |
Array
(
[id] => 3729448
[patent_doc_number] => 05635383
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-03
[patent_title] => 'Method for the introduction of genes into mammalian cells by a soluble molecular complex comprising a receptor ligand and a polycation'
[patent_app_type] => 1
[patent_app_number] => 8/368757
[patent_app_country] => US
[patent_app_date] => 1995-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 5655
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/635/05635383.pdf
[firstpage_image] =>[orig_patent_app_number] => 368757
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/368757 | Method for the introduction of genes into mammalian cells by a soluble molecular complex comprising a receptor ligand and a polycation | Jan 3, 1995 | Issued |
| 08/368574 | METHODS AND COMPOSITIONS FOR TREATMENT OF SOLID TUMORS IN VIVO | Dec 29, 1994 | Abandoned |
Array
(
[id] => 1309826
[patent_doc_number] => 06610287
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication'
[patent_app_type] => B1
[patent_app_number] => 08/363998
[patent_app_country] => US
[patent_app_date] => 1994-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20127
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610287.pdf
[firstpage_image] =>[orig_patent_app_number] => 08363998
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/363998 | Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication | Dec 26, 1994 | Issued |
Array
(
[id] => 3804029
[patent_doc_number] => 05830754
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Recombinant DNA-produced T11 and fragments thereof'
[patent_app_type] => 1
[patent_app_number] => 8/361014
[patent_app_country] => US
[patent_app_date] => 1994-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4516
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830754.pdf
[firstpage_image] =>[orig_patent_app_number] => 361014
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/361014 | Recombinant DNA-produced T11 and fragments thereof | Dec 20, 1994 | Issued |
Array
(
[id] => 6340629
[patent_doc_number] => 20020034495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'GENE THERAPY'
[patent_app_type] => new
[patent_app_number] => 08/361198
[patent_app_country] => US
[patent_app_date] => 1994-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9731
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20020034495.pdf
[firstpage_image] =>[orig_patent_app_number] => 08361198
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/361198 | GENE THERAPY | Dec 20, 1994 | Abandoned |
Array
(
[id] => 1553765
[patent_doc_number] => 06348449
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-19
[patent_title] => 'Methods of inducing mucosal immunity'
[patent_app_type] => B1
[patent_app_number] => 08/357398
[patent_app_country] => US
[patent_app_date] => 1994-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 8
[patent_no_of_words] => 20502
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/348/06348449.pdf
[firstpage_image] =>[orig_patent_app_number] => 08357398
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/357398 | Methods of inducing mucosal immunity | Dec 15, 1994 | Issued |
| 08/355087 | ADENOVIRAL VECTORS AND PRODUCER CELLS | Dec 11, 1994 | Abandoned |
Array
(
[id] => 3618940
[patent_doc_number] => 05601818
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'Cancer therapy utilizing malignant cells expressing HSV-TK'
[patent_app_type] => 1
[patent_app_number] => 8/351891
[patent_app_country] => US
[patent_app_date] => 1994-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11991
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/601/05601818.pdf
[firstpage_image] =>[orig_patent_app_number] => 351891
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/351891 | Cancer therapy utilizing malignant cells expressing HSV-TK | Dec 7, 1994 | Issued |